Form 8-K - Current report:
SEC Accession No. 0001628280-24-042948
Filing Date
2024-10-16
Accepted
2024-10-16 17:16:29
Documents
29
Period of Report
2024-10-16
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20241016.htm   iXBRL 8-K 28483
2 EX-3.1 aquestiveamendedandresta.htm EX-3.1 77282
6 aquestiveamendedandresta001.jpg GRAPHIC 259505
7 aquestiveamendedandresta002.jpg GRAPHIC 315225
8 aquestiveamendedandresta003.jpg GRAPHIC 338019
9 aquestiveamendedandresta004.jpg GRAPHIC 340091
10 aquestiveamendedandresta005.jpg GRAPHIC 364081
11 aquestiveamendedandresta006.jpg GRAPHIC 325191
12 aquestiveamendedandresta007.jpg GRAPHIC 323647
13 aquestiveamendedandresta008.jpg GRAPHIC 274359
14 aquestiveamendedandresta009.jpg GRAPHIC 281402
15 aquestiveamendedandresta010.jpg GRAPHIC 275730
16 aquestiveamendedandresta011.jpg GRAPHIC 278252
17 aquestiveamendedandresta012.jpg GRAPHIC 261277
18 aquestiveamendedandresta013.jpg GRAPHIC 342084
19 aquestiveamendedandresta014.jpg GRAPHIC 199791
20 aquestiveamendedandresta015.jpg GRAPHIC 110842
  Complete submission text file 0001628280-24-042948.txt   6168164

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20241016.xsd EX-101.SCH 1895
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20241016_lab.xml EX-101.LAB 22532
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20241016_pre.xml EX-101.PRE 13039
31 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20241016_htm.xml XML 2819
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 241375366
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)